<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh">
	<id>https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=SIB-1893</id>
	<title>SIB-1893 - 版本历史</title>
	<link rel="self" type="application/atom+xml" href="https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=SIB-1893"/>
	<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=SIB-1893&amp;action=history"/>
	<updated>2026-07-18T19:20:26Z</updated>
	<subtitle>本wiki上该页面的版本历史</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://arolstar52-zhtest.hf.space/index.php?title=SIB-1893&amp;diff=3777047&amp;oldid=prev</id>
		<title>imported&gt;147258et：​內容擴充 增加或調整內部連結</title>
		<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=SIB-1893&amp;diff=3777047&amp;oldid=prev"/>
		<updated>2025-11-01T14:03:57Z</updated>

		<summary type="html">&lt;p&gt;內容擴充 增加或調整內部連結&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新页面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Drugbox&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| Watchedfields = changed&lt;br /&gt;
| verifiedrevid = 402053704&lt;br /&gt;
| IUPAC_name = (E)-2-methyl-6-(2-phenylethenyl)pyridine&lt;br /&gt;
| image = SIB-1893_structure.png&lt;br /&gt;
| width = 200&lt;br /&gt;
| ChEMBL_Ref = {{ebicite|changed|EBI}}&lt;br /&gt;
| ChEMBL = 88612&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename = &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| legal_AU = &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
| legal_CA = &amp;lt;!-- / Schedule I, II, III, IV, V, VI, VII, VIII --&amp;gt;&lt;br /&gt;
| legal_UK = &amp;lt;!-- GSL / P / POM / CD / Class A, B, C --&amp;gt;&lt;br /&gt;
| legal_US = &amp;lt;!-- OTC / Rx-only / Schedule I, II, III, IV, V --&amp;gt;&lt;br /&gt;
| legal_status = &lt;br /&gt;
| routes_of_administration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability = &lt;br /&gt;
| protein_bound = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|CAS}}&lt;br /&gt;
| CAS_number = 7370-21-0&lt;br /&gt;
| CAS_number_Comment = &amp;#039;&amp;#039;trans&amp;#039;&amp;#039;&lt;br /&gt;
| CAS_number2 = 6266-99-5&lt;br /&gt;
| CAS_number2_Ref = {{cascite|correct|CAS}}&lt;br /&gt;
| ATC_prefix = &lt;br /&gt;
| ATC_suffix = &lt;br /&gt;
| PubChem = 235382&lt;br /&gt;
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}&lt;br /&gt;
| DrugBank =&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}&lt;br /&gt;
| ChemSpiderID      = 4470920&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = 4X2F5X24UK&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=14 | H=13 | N=1&lt;br /&gt;
| smiles = c1ccccc1\C=C\c(nc2C)ccc2&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}&lt;br /&gt;
| StdInChI          = 1S/C14H13N/c1-12-6-5-9-14(15-12)11-10-13-7-3-2-4-8-13/h2-11H,1H3/b11-10+&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}&lt;br /&gt;
| StdInChIKey       = SISOFUCTXZKSOQ-ZHACJKMWSA-N&lt;br /&gt;
}}&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;SIB-1893&amp;#039;&amp;#039;&amp;#039;是一种[[有机化合物]]，化学式为C&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;13&amp;lt;/sub&amp;gt;N。它可由2-甲基-6-苯乙炔基吡啶和[[硫化钠]]九水合物在[[二甲基甲酰胺]]中于140 °C反应制得。&amp;lt;ref&amp;gt;{{cite journal|journal=Organic Letters|volume=16|issue=11|language=en|issn=1523-7060|date=2014-06-06|pages=3020–3023|doi=10.1021/ol501137x|url=https://pubs.acs.org/doi/10.1021/ol501137x|title=Transition-Metal-Free Semihydrogenation of Diarylalkynes: Highly Stereoselective Synthesis of trans -Alkenes Using Na 2 S·9H 2 O|accessdate=2021-09-21|author=Zhengwang Chen, Miaoting Luo, Yuelu Wen, Guotian Luo, Liangxian Liu|archive-date=2021-09-21|archive-url=https://web.archive.org/web/20210921060414/https://pubs.acs.org/doi/10.1021/ol501137x}}&amp;lt;/ref&amp;gt;以[[苯甲醛]]和[[2,6-二甲基吡啶]]为原料在路易斯酸催化下反应，也可得到该化合物。&amp;lt;ref&amp;gt;{{cite journal|journal=European Journal of Organic Chemistry|volume=2014|issue=14|language=en|date=2014-05|pages=3009–3019|doi=10.1002/ejoc.201400073|url=https://onlinelibrary.wiley.com/doi/10.1002/ejoc.201400073|title=Lewis-Acid-Catalyzed Benzylic Reactions of 2-Methylazaarenes with Aldehydes: Benzylic Reactions of 2-Methylazaarenes|accessdate=2021-09-21|author=Dan Mao, Gang Hong, Shengying Wu, Xin Liu, Jianjun Yu, Limin Wang}}&amp;lt;/ref&amp;gt;在[[草酸]]二水合物的存在下，它可以发生光[[二聚作用|二聚反应]]（又稱二聚作用），得到1,3-二苯基-2,4-二(6-甲基吡啶-2-基)环丁烷&amp;lt;!-- CAS 2414635-38-2 --&amp;gt;。&amp;lt;ref&amp;gt;{{cite journal|journal=Chemistry – A European Journal|volume=26|issue=21|language=en|issn=0947-6539|date=2020-04-09|pages=4682–4689|doi=10.1002/chem.201905597|url=https://onlinelibrary.wiley.com/doi/10.1002/chem.201905597|title=[2+2] Photodimerization of Stilbazoles Promoted by Oxalic Acid in Suspension|accessdate=2021-09-21|author=Thanh Binh Nguyen, Tuan Minh Nguyen, Pascal Retailleau}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==参考文献==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:吡啶]]&lt;br /&gt;
[[Category:受体拮抗剂]]&lt;br /&gt;
[[Category:乙烯基苯]]&lt;/div&gt;</summary>
		<author><name>imported&gt;147258et</name></author>
	</entry>
</feed>